These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35054125)
1. The Clinical Impact of Combining Neutrophil-to-Lymphocyte Ratio with Sarcopenia for Improved Discrimination of Progression-Free Survival in Patients with Colorectal Cancer. Lee SY; Chung E; Cho ES; Lee JH; Park EJ; Shin SJ; Baik SH; Lee KY; Kang J J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054125 [TBL] [Abstract][Full Text] [Related]
2. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857 [TBL] [Abstract][Full Text] [Related]
3. Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer. Kim JH; Lee JH; Lee HS; Shin SJ; Park EJ; Cho ES; Baik SH; Lee KY; Kang J J Inflamm Res; 2021; 14():4457-4466. PubMed ID: 34522115 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of Sarcopenia and the Neutrophil-to-Lymphocyte Ratio in Elderly Patients with Esophageal Squamous Cell Carcinoma. Peng H; Tan X Cancer Manag Res; 2021; 13():3209-3218. PubMed ID: 33880063 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients. Lee BM; Cho Y; Kim JW; Jeung HC; Lee IJ Front Oncol; 2020; 10():1581. PubMed ID: 32984018 [No Abstract] [Full Text] [Related]
6. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer]. Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334 [TBL] [Abstract][Full Text] [Related]
7. Associations of Systemic Inflammation and Sarcopenia With Survival of Esophageal Carcinoma Patients. Sugawara K; Yagi K; Uemura Y; Okumura Y; Nishida M; Aikou S; Yamashita H; Seto Y Ann Thorac Surg; 2020 Aug; 110(2):374-382. PubMed ID: 32278754 [TBL] [Abstract][Full Text] [Related]
8. Impact of Body Composition on Prognosis and Dose-Limiting Toxicities on Metastatic Colorectal Cancer. da Silva Dias D; Machado M; Trabulo C; Gosálbez B; Ravasco P Front Nutr; 2021; 8():671547. PubMed ID: 35155507 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer. Xie H; Wei L; Gao S; Liu M; Liang Y; Yuan G; Wang Q; Xu Y; Tang S; Gan J Front Nutr; 2023; 10():1076589. PubMed ID: 36819674 [TBL] [Abstract][Full Text] [Related]
10. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer. Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer. Zhou M; Li L; Wang X; Wang C; Wang D Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641 [TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab. Shimizu T; Miyake M; Hori S; Ichikawa K; Omori C; Iemura Y; Owari T; Itami Y; Nakai Y; Anai S; Tomioka A; Tanaka N; Fujimoto K Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429323 [TBL] [Abstract][Full Text] [Related]
14. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713 [No Abstract] [Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. Shin K; Jung EK; Park SJ; Jeong S; Kim IH; Lee MA World J Gastrointest Oncol; 2021 Aug; 13(8):915-928. PubMed ID: 34457195 [TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
17. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400 [TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma. Fukata S; Mizutani K; Yamamoto S; Kuno T; Fukuhara H; Ashida S; Karashima T; Inoue K Anticancer Drugs; 2022 Jun; 33(5):459-466. PubMed ID: 35417424 [TBL] [Abstract][Full Text] [Related]
19. Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone. Zhan X; Sun X; Hong Y; Wang Y; Ding K Biomed Res Int; 2017; 2017():3809464. PubMed ID: 28685148 [TBL] [Abstract][Full Text] [Related]
20. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]